César Caro Martínez-rekin lankidetzan egindako argitalpenak (7)

2020

  1. Aortic valve stenosis provides complementary information to bleeding risk scores in non-valvular atrial fibrillation patients initiating anticoagulation

    Journal of Geriatric Cardiology, Vol. 17, Núm. 3, pp. 141-148

2019

  1. Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists

    European Journal of Clinical Investigation, Vol. 49, Núm. 10

  2. Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry

    Current Medical Research and Opinion, Vol. 35, Núm. 8, pp. 1463-1471

  3. Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 935-943

  4. Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry

    Current Medical Research and Opinion, Vol. 35, Núm. 12, pp. 2035-2041

2018

  1. Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke

    Future Cardiology, Vol. 14, Núm. 3s, pp. 31-37

  2. Kidney function monitoring and nonvitamin K oral anticoagulant dosage in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 48, Núm. 6